LONDON, June 14 Swiss drugs company Novartis
NOVN.VX will not give free vaccines against H1N1 flu to poor
countries, though it will consider discounts, the Financial
Times reported on Sunday.
"If you want to make production sustainable, you have to
create financial incentives," the FT quoted Novartis Chief
Executive Daniel Vasella as saying in an early edition of
The director-general of the World Health Organisation,
Margaret Chan, has called for drugs companies to show
solidarity with poor countries as they develop vaccines against
the pandemic H1N1 virus, commonly known as swine flu.
As well as Novartis, U.S. company Baxter International
(BAX.N) and Europe's Sanofi-Aventis (SASY.PA), GlaxoSmithKline
(GSK.L) and Solvay (SOLB.BR) are working on vaccines.
H1N1 has infected around 30,000 people globally, mostly in
North America, though there have been few deaths outside Mexico
and the United States. Europe suffered its first death on
Sunday after a patient with pre-existing health problems died
(Reporting by David Milliken; Editing Bernard Orr)